Liver transplant drug trial halted early – only 6 patients enrolled
NCT ID NCT05514119
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 24 times
Summary
This study tested whether the drug fenofibrate could prevent bile duct damage in people who received a liver from a donor after circulatory death. Only 6 patients took part before the study was stopped. The main goal was to see if patients could tolerate the drug without serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic Arizona
Phoenix, Arizona, 85254, United States
Conditions
Explore the condition pages connected to this study.